DiPALS: diaphragm pacing in patients with amyotrophic lateral sclerosis - a randomised controlled trial

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease resulting in death, usually from respiratory failure, within 2-3 years of symptom onset. Non-invasive ventilation (NIV) is a treatment that when given to patients in respiratory failure leads to improved survival and quality of life....

Full description

Bibliographic Details
Main Authors:	McDermott, C, Bradburn, M, Maguire, C, Cooper, C, Baird, W, Baxter, S, Cohen, J, Cantrill, H, Dixon, S, Ackroyd, R, Baudouin, S, Bentley, A, Berrisford, R, Bianchi, S, Bourke, S, Darlison, R, Ealing, J, Elliott, M, Fitzgerald, P, Galloway, S, Hamdalla, H, Hanemann, C, Hughes, P, Imam, I, Karat, D, Leek, R, Maynard, N, Orrell, R, Sarela, A, Stradling, J, Talbot, K, Taylor, L, Turner, M, Simonds, A, Williams, T, Wedzicha, W, Young, C, Shaw, P
Format:	Journal article
Language:	English
Published:	NIHR Health Technology Assessment Programme 2016

DiPALS: diaphragm pacing in patients with amyotrophic lateral sclerosis - a randomised controlled trial

Similar Items